Response: [adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: randomized clinical trial]

Irwin Gross and Michael Auerbach address questions related to oral vs intravenous iron substitution in cancer patients receiving erythropoiesis stimulating agen

Saved in:

Bibliographic Details
Main Authors:	Möbus, Volker (Author) , Jackisch, Christian (Author) , Schneeweiss, Andreas (Author) , Huober, Jens (Author) , Lück, Hans-Joachim (Author) , Du Bois, Andreas (Author) , Thomssen, Christoph (Author) , Kurbacher, Christian M. (Author) , Kuhn, Walther (Author) , Nitz, Ulrike A. (Author) , Runnebaum, Ingo B. (Author) , Hinke, Axel (Author) , Kreienberg, Rolf (Author) , Untch, Michael (Author)
Format:	Article (Journal) Editorial
Language:	English
Published:	28 February 2014
In:	Journal of the National Cancer Institute Year: 2014, Volume: 106, Issue: 3, Pages: 452
ISSN:	1460-2105
DOI:	10.1093/jnci/djt452
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/jnci/djt452 Verlag, Volltext: http://www.ncbi.nlm.nih.gov/pubmed?term=24586093 Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/jnci/article/106/3/djt452/977620
Author Notes:	Volker Moebus, Christian Jackisch, Andreas Schneeweiss, Jens Huober, Hans-Joachim Lueck, Andreas du Bois, Christoph Thomssen, Christian Kurbacher, Walther Kuhn, Ulrike A. Nitz, Ingo B. Runnebaum, Axel Hinke, Rolf Kreienberg, Michael Untch, AGO Breast Study Group

Description
Summary:	Irwin Gross and Michael Auerbach address questions related to oral vs intravenous iron substitution in cancer patients receiving erythropoiesis stimulating agen
Physical Description:	Online Resource
ISSN:	1460-2105
DOI:	10.1093/jnci/djt452